Varian claims key role in Spanish IGRT installation
This article was originally published in Clinica
Executive Summary
Varian Medical Systems is claiming a major role in equipping the first hospital in northern Spain to offer state-of-the-art image-guided radiotherapy (IGRT), after installing three linacs, other equipment and related guidance systems at a new centre. Hospital General de Navarra, in the city of Pamplona, has installed Spain's second only Trilogy linac, "full accessorised" with its On-Board Imager guidance system, said the Palo Alto, California firm. It has also supplied two Clinac 21EX accelerators; an Acuity cone-beam CT, a full ARIA suite and Eclipse treatment planning software. Dr Anastasio Rubio Arroniz, chief of radiotherapy physics, said this represented a step-change in the region's capacity to provide IGRT, intensity-modulated (IMRT) and whole-body stereotactic radiosurgery (SRS) - the latter is to be offered in the near future, he said. The hospital serves a population of 600,000, including 1,200 cancer patients per year.
You may also be interested in...
Post-Brexit UK Risks Being ‘Left Out In The Cold’ As EU Coordinates Action On Shortages
The UK is not alone in experiencing drug shortages, as data from across Europe show, but its departure from the EU makes it more difficult to respond to supply chain pressures, according to new research.
Dr Reddy’s Knocked Back On Rituximab In US
Dr Reddy’s has received a complete response letter from the US FDA, knocking back its proposed rituximab biosimilar rival to Rituxan.
Sandoz And Samsung Celebrate Stelara Rival’s EU Approval
Sandoz and Samsung Bioepis have received final European Commission approval for their partnered Pyzchiva biosimilar rival to Stelara. But with European competition on ustekinumab due to kick off in just a matter of months, further applicants are also waiting in the wings.